Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Moderna: The COVID-19 Upside Appears Priced In

PFE - Moderna: The COVID-19 Upside Appears Priced In

Pfizer Inc.
  • Moderna's COVID-19 vaccine has shown efficacy on par with Pfizer's. However, PFE will be first to market.
  • MRNA's vaccine could generate $11 billion in 2021 revenue. The company trades at 5.6x 2021 projected COVID-19 revenue.
  • Moderna's revenue is expected to decline over time. Its valuation is likely too robust compared to recurring revenue.
  • AstraZeneca is paying 6.5x recurring revenue for ALXN. Once MRNA's recurring revenue materializes the stock will likely fall.
  • Sell MRNA.

For further details see:

Moderna: The COVID-19 Upside Appears Priced In
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...